Compare Excaliard Pharmaceuticals vs Mast Therapeutics
Customers evaluate the quality of Excaliard Pharmaceuticals's products using the following success metrics.
Overview
Excaliard Pharmaceuticals is based in United States
Excaliard Pharmaceuticals is a biopharmaceutical company focused on developing drugs for the local treatment of fibrosis, including skin scarring.
Mast Therapeutics is 29 yrs old and is based in United States.
Mast Therapeutics (NYSEMKT: MSTX), fka ADVENTRX Pharmaceuticals, is a biopharmaceutical company focused on in-licensing, developing, and commercializing proprietary product candidates primarily for the treatment of cancer. Mast's lead product candidate, AIR001, is a sodium nitrite solution for intermittent inhalation via nebulization in Phase 2 clinical development for the treatment of HFpEF.
Demo Video
Leadership
J. Gordon Foulkes (Chief Executive Officer)
Carrie McQueen (Chief Financial Officer)
Investors
Pfizer, Alta Partners
Savara, Centrum Bank AG
Product
Benefits
Products
Customers
Known Partners
Why They Buy
Information not available because Excaliard Pharmaceuticals has not claimed their profile.
Work for Excaliard Pharmaceuticals? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Excaliard Pharmaceuticals?
Claim your profile now.
Information not available because Mast Therapeutics has not claimed their profile.
Work for Mast Therapeutics? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Mast Therapeutics?
Claim your profile now.